Cargando…

Novel potential biomarkers for severe alcoholic liver disease

BACKGROUND: Alcoholic liver disease (ALD) is a leading cause of advanced liver disease; however, minor clinical symptoms in the early stage frequently result in delayed diagnosis and therapy. Invasive liver biopsy, the gold standard for diagnosing ALD, is unsuitable for repetitive analysis. This stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jia, Yu, Jiachi, Wang, Jianan, Liu, Jiayu, Xie, Wei, Li, Ruibing, Wang, Chengbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794087/ https://www.ncbi.nlm.nih.gov/pubmed/36582223 http://dx.doi.org/10.3389/fimmu.2022.1051353

Ejemplares similares

UCHL1 from serum and CSF is a candidate biomarker for amyotrophic lateral sclerosis
por: Li, Ruibing, et al.
Publicado: (2020)

Two novel mutations of COL1A1 in fetal genetic skeletal dysplasia of Chinese
por: Li, Ruibing, et al.
Publicado: (2020)

Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
por: Wang, Jianan, et al.
Publicado: (2022)

Potential plasma biomarkers at low altitude for prediction of acute mountain sickness
por: Guo, Haoran, et al.
Publicado: (2023)

The Role of Mitochondrial Quality Control in Cardiac Ischemia/Reperfusion Injury
por: Huang, Jia, et al.
Publicado: (2021)

Soluble TREM2 is a potential biomarker for the severity of primary angiitis of the CNS
por: Guo, Tianshu, et al.
Publicado: (2022)

Six potential biomarkers in septic shock: a deep bioinformatics and prospective observational study
por: Kong, Chang, et al.
Publicado: (2023)

Circulatory levels of alarmins in patients with non-segmental vitiligo: Potential biomarkers for disease diagnosis and activity/severity assessment
por: He, Kaiqiao, et al.
Publicado: (2022)

The Potential Role of Gut Microbial-Derived Exosomes in Metabolic-Associated Fatty Liver Disease: Implications for Treatment
por: Zhang, Binbin, et al.
Publicado: (2022)

Myeloid cells in alcoholic liver diseases: Mechanism and prospect
por: Xu, Wentao, et al.
Publicado: (2022)

Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells
por: Wei, Zhenyu, et al.
Publicado: (2023)

Helminth infection and helminth-derived products: A novel therapeutic option for non-alcoholic fatty liver disease
por: Liu, Xi, et al.
Publicado: (2022)

Analysis of potential immune-related genes involved in the pathogenesis of ischemia-reperfusion injury following liver transplantation
por: Guo, Jiayu, et al.
Publicado: (2023)

Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease
por: Li, Sha, et al.
Publicado: (2019)

Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2020)

Characterization of METRNβ as a novel biomarker of Coronavirus disease 2019 severity and prognosis
por: Gao, Xun, et al.
Publicado: (2023)

Potentiality of Exosomal Proteins as Novel Cancer Biomarkers for Liquid Biopsy
por: Hu, Chunmiao, et al.
Publicado: (2022)

Extracellular vesicles as potential biomarkers and treatment options for liver failure: A systematic review up to March 2022
por: Lu, Wang, et al.
Publicado: (2023)

Analysis of Gene Expression Profiles, Cytokines, and Bacterial Loads Relevant to Alcoholic Liver Disease Mice Infected With V. vulnificus
por: Feng, Zi-Han, et al.
Publicado: (2021)

CD247, a Potential T Cell–Derived Disease Severity and Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis
por: Li, Yupeng, et al.
Publicado: (2021)

Circulating mitochondrial cell-free DNA dynamics in patients with mycobacterial pulmonary infections: Potential for a novel biomarker of disease
por: Pan, Sheng-Wei, et al.
Publicado: (2022)

Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease
por: Vonghia, Luisa, et al.
Publicado: (2019)

Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy
por: Li, Ruibing, et al.
Publicado: (2018)

Kinetics of Severity Biomarkers and Immunological Features of Methylprednisolone Therapy for Severe COVID-19 Patients
por: Fan, Qinghong, et al.
Publicado: (2022)

Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets
por: Paquissi, Feliciano Chanana
Publicado: (2016)

Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
por: Duan, Yamei, et al.
Publicado: (2022)

Macrophages and the development and progression of non-alcoholic fatty liver disease
por: Alabdulaali, Bader, et al.
Publicado: (2023)

Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2022)

Critical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: From Basic Science to Clinical Trials
por: Zeng, Tao, et al.
Publicado: (2016)

Alcohol Consumption and Risk of Liver Fibrosis in People Living With HIV: A Systematic Review and Meta-Analysis
por: Lyu, Hang, et al.
Publicado: (2022)

Monofloral Triadica Cochinchinensis Honey Polyphenols Improve Alcohol-Induced Liver Disease by Regulating the Gut Microbiota of Mice
por: Luo, Liping, et al.
Publicado: (2021)

The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
por: Van Herck, Mikhaïl A., et al.
Publicado: (2019)

NLRP3: a new therapeutic target in alcoholic liver disease
por: Brahadeeswaran, Subhashini, et al.
Publicado: (2023)

Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis of Adult-Onset Still’s Disease
por: Sun, Yue, et al.
Publicado: (2020)

Interaction between dual specificity phosphatase-1 and cullin-1 attenuates alcohol-related liver disease by restoring p62-mediated mitophagy
por: Li, Ruibing, et al.
Publicado: (2023)

ERO1L Is a Novel and Potential Biomarker in Lung Adenocarcinoma and Shapes the Immune-Suppressive Tumor Microenvironment
por: Liu, Lihui, et al.
Publicado: (2021)

The association between non-alcoholic fatty liver disease and atopic dermatitis: a population-based cohort study
por: Gau, Shuo-Yan, et al.
Publicado: (2023)

Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis
por: Wu, Man-Ning, et al.
Publicado: (2023)

Endoplasmic reticulum stress in innate immune cells - a significant contribution to non-alcoholic fatty liver disease
por: Zhou, Liangliang, et al.
Publicado: (2022)

Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease
por: Stiglund, Natalie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a0fvctt91nf1ut51s0g46vaine